PHG vs LNTH vs HTFL Stock Comparison

Koninklijke Philips, Lantheus Holdings and Heartflow Prices as of Oct 26, 2026 Peers: Industry group
PHG Koninklijke Philips Nv
$26.56 +6.4% 1M -7.9% 1Y
Market cap
$25.13B
P/E
13.6x
Revenue (TTM)
$20.60B
Div. yield
–
Diagnostic Equipment Healthcare
4 wins
LNTH Lantheus Holdings, Inc.
$99.92 +0.2% 1M +78.2% 1Y
Market cap
$6.52B
P/E
23.7x
Revenue (TTM)
$1.56B
Div. yield
–
Diagnostic Equipment Healthcare
6 wins
HTFL Heartflow, Inc.
$57.01 +15.9% 1M +50.5% 1Y
Market cap
$5.14B
P/E
–
Revenue (TTM)
$202.91M
Div. yield
–
Diagnostic Equipment Healthcare
1 win

Head to Head

11 decided of 12

Lantheus Holdings leads on 6 of the 12 questions below (Lantheus Holdings 6, Koninklijke Philips 4, Heartflow 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionPHGLNTHHTFLLeader
Larger companyMarket capitalisation $25.13B $6.52B $5.14B PHG
Cheaper on earningsLower P/E, profitable companies only 13.6x 23.7x -51.3x PHG
Cheaper on forward earningsLower price / next fiscal year consensus EPS 13.4x 17.3x — PHG
Faster revenue growthRevenue growth, trailing twelve months +6.1% +2.3% +42.5% HTFL
More profitableNet margin, trailing twelve months 8.9% 17.7% -49.4% LNTH
Better return on capitalReturn on invested capital 11.5% 12.5% — LNTH
Less leveragedLower net debt / EBITDA 1.8x -0.1x — LNTH
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -7.9% +78.2% +50.5% LNTH
Better 5-year returnAnnualised price return, 5 years -10.8%/yr +34.7%/yr — LNTH
Less volatileAnnualised volatility, 1 year 28.8% 32.4% 76.9% PHG
Higher overall scoreMean of the five percentile scores vs peers 80/100 80/100 57/100 LNTH

Percentile Scorecard

PHGLNTHHTFL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisPHGLNTHHTFL
Valuation 98 #6 of 228 81 #45 of 228 8 #209 of 228
Growth 96 #11 of 221 63 #83 of 221 78 #50 of 221
Profitability 96 #10 of 208 94 #13 of 208 49 #107 of 208
Financial Health 31 #166 of 239 69 #74 of 239 91 #22 of 239
Shareholder Returns 79 #29 of 137 93 #11 of 137 –
Overall 80 80 57
  • PHG ranked among 248 companies in Medical Devices and Diagnostics
  • LNTH ranked among 248 companies in Medical Devices and Diagnostics
  • HTFL ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodPHGLNTHHTFLSPY
1 month +6.4%+0.2%+15.9% -0.8%
3 months +6.2%-7.5%+124.7% +3.5%
6 months -3.6%+18.8%+79.7% +7.0%
Year to date -1.9%+50.1%+95.6% +12.2%
1 year -7.9%+78.2%+50.5% +13.0%
3 years +43.6%+49.5%— +86.3%
3 years, per year +12.8%+14.4%— +23.1%
5 years -43.6%+343.3%— +68.6%
5 years, per year -10.8%+34.7%— +11.0%
10 years -11.6%+1,048.5%— +258.0%
10 years, per year -1.2%+27.7%— +13.6%

Risk

MeasurePHGLNTHHTFLSPY
Volatility, 1Y 28.8%32.4%76.9% 12.7%
Downside volatility, 1Y 28.8%27.5%77.5% 12.7%
Beta vs S&P 500, 1Y 0.810.591.90 1.00
Return / volatility, 1Y -0.272.420.66 1.02
Max drawdown, 5Y -75.6%-59.5%-48.7% -25.4%
From 52-week high -19.3%-9.9%0.0% -1.8%
52-week high $32.91$110.94$57.01 $779.14
52-week low $23.81$50.69$20.49 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultiplePHGLNTHHTFL
P/E now vs peer median 13.7xmedian 30.6x 23.6xmedian 30.6x -49.2xmedian 30.6x
P/S now vs peer median 1.2xmedian 3.0x 4.2xmedian 3.0x 24.4xmedian 3.0x
EV/EBITDA now vs peer median 8.1xmedian 17.5x 16.4xmedian 17.5x —median 17.5x
P/FCF now vs peer median 5.9xmedian 23.3x 16.8xmedian 23.3x —median 23.3x
P/B now vs peer median 2.0xmedian 2.4x 5.0xmedian 2.4x 17.7xmedian 2.4x
PEG now vs peer median 0.32median 0.87 0.22median 0.87 —median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsPHGLNTHHTFL
Revenue $20.60B $1.56B $202.91M
Gross profit $16.03B $936.02M $160.45M
Operating income $2.65B $302.34M -$64.46M
Net income $1.39B $275.31M -$100.19M
Free cash flow $4.34B $387.83M –
R&D $2.00B $173.09M $77.26M
EPS (diluted) $1.91 $4.08 $-1.16
Cash & equivalents $2.04B $593.30M $34.36M
Total debt $9.51B $571.05M –
Shares (diluted) 962.50M 67.52M 86.40M
Enterprise value $14.24B $4.69B $4.90B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricPHGLNTHHTFL
P/E 13.7x 23.6x -49.2x
P/FCF 5.9x 16.8x –
P/Operating cash flow 9.6x 15.8x –
P/S 1.2x 4.2x 24.4x
P/B 2.0x 5.0x 17.7x
P/Tangible book 2.5x 10.5x 17.7x
EV/EBITDA 8.1x 16.4x –
EV/EBIT 12.4x 21.5x -72.9x
EV/Revenue 1.6x 4.2x 23.1x
EV/FCF 7.6x 16.8x –
EV/Operating cash flow 12.4x 15.7x –
PEG (3Y EPS CAGR) 0.32 0.22 –

Growth

14 metrics
MetricPHGLNTHHTFL
Revenue growth (1Y) 6.1% 2.3% 42.5%
Revenue CAGR (3Y) 2.3% 11.4% –
Gross profit growth (1Y) 82.4% -3.4% 48.8%
Gross profit CAGR (3Y) 6.7% 16.3% –
Operating income growth (1Y) 121.3% -30.9% -9.5%
Operating income CAGR (3Y) 52.0% 118.8% –
Net income growth (1Y) 293.5% 1.6% -18.3%
Net income CAGR (3Y) 35.6% 102.1% –
EPS growth (1Y) 539.4% 5.8% 91.4%
EPS CAGR (3Y) 42.2% 105.5% –
Operating cash flow growth (1Y) 116.7% -21.7% –
Operating cash flow CAGR (3Y) 53.6% 14.5% –
Free cash flow growth (1Y) 54.2% -10.1% –
Free cash flow CAGR (3Y) 45.6% 103.0% –

Profitability

14 metrics
MetricPHGLNTHHTFL
Gross margin 77.8% 60.1% 79.1%
EBITDA margin 19.8% 25.4% –
Operating margin 12.9% 19.4% -31.8%
Pretax margin 11.9% 23.3% -49.4%
Net margin 8.9% 17.7% -49.4%
FCF margin 21.1% 24.9% –
Operating cash flow margin 12.9% 26.5% –
Return on equity 12.7% 21.8% -34.5%
Return on assets 5.4% 11.6% -28.5%
Return on invested capital 11.5% 12.5% –
Return on capital employed 11.8% 14.8% -20.9%
Asset turnover 0.7x 0.7x 0.6x
Cash conversion (OCF / net income) 1.9x 1.5x –
Stock comp / revenue 0.7% 5.0% 9.6%

Financial Health

11 metrics
MetricPHGLNTHHTFL
Debt / assets 31.2% 23.6% –
Debt / equity 0.7x 0.4x –
Net debt / EBITDA 1.8x -0.1x –
Debt / FCF 2.2x 1.5x –
Liabilities / assets 57.1% 45.7% 18.8%
Equity / assets 42.9% 54.3% 81.2%
Interest coverage 6.2x 15.3x –
Current ratio 1.3x 3.1x 5.1x
Quick ratio 0.7x 2.8x 6.6x
Cash ratio 0.2x 1.8x 5.6x
Altman Z-score – 5.46 41.82

Shareholder Returns

7 metrics
MetricPHGLNTHHTFL
Dividend yield 3.7% – –
Net buyback yield -0.5% 2.9% –
Shareholder yield 3.3% 2.9% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusPHGLNTHHTFL
Forward P/E 13.4xFY2026 17.3xFY2026 –
EPS, next fiscal year $1.98FY2026 $5.76FY2026 $-0.43FY2026
EPS growth, next FY +6.5%FY2026 -5.3%FY2026 –
EPS growth, the year after -10.1% +4.2% –
Revenue, next fiscal year $21.63BFY2026 $1.57BFY2026 $261.38MFY2026
Revenue growth, next FY +1.8%FY2026 +1.8%FY2026 +48.5%FY2026
Revenue growth, the year after -8.2% +12.7% +20.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersPHGLNTHHTFL
Held by institutions 5.4% 100.0% 100.0%
Institutions holding 363 465 192
Change in shares held, QoQ +0.8% +3.4% +133.0%
Institutions buying 266 248 140
Institutions selling 76 142 38
Buyers to sellers 3.50 1.75 3.68

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

PHGLNTHHTFL
PHG 1.00 0.19 0.14
LNTH 0.19 1.00 0.14
HTFL 0.14 0.14 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, PHG, LNTH and HTFL?

Koninklijke Philips (PHG) is the largest by market capitalisation: Koninklijke Philips (PHG) $25.13B, Lantheus Holdings (LNTH) $6.52B, Heartflow (HTFL) $5.14B.

Which stock is cheaper, PHG, LNTH and HTFL?

Koninklijke Philips (PHG) trades on the lowest price-to-earnings ratio (Koninklijke Philips (PHG) 13.6x, Lantheus Holdings (LNTH) 23.7x, Heartflow (HTFL) -51.3x). On next year's consensus earnings, Koninklijke Philips (PHG) is cheapest (Koninklijke Philips (PHG) 13.4x, Lantheus Holdings (LNTH) 17.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Heartflow (HTFL) grew revenue fastest over the trailing twelve months: Koninklijke Philips (PHG) +6.1%, Lantheus Holdings (LNTH) +2.3%, Heartflow (HTFL) +42.5%.

Which company is more profitable?

Lantheus Holdings (LNTH) has the highest net margin (Koninklijke Philips (PHG) 8.9%, Lantheus Holdings (LNTH) 17.7%, Heartflow (HTFL) -49.4%). On return on invested capital, Lantheus Holdings (LNTH) leads (Koninklijke Philips (PHG) 11.5%, Lantheus Holdings (LNTH) 12.5%).

Which stock has performed better?

Over the past year Lantheus Holdings (LNTH) returned the most: Koninklijke Philips (PHG) -7.9%, Lantheus Holdings (LNTH) +78.2%, Heartflow (HTFL) +50.5%. Over five years, Lantheus Holdings (LNTH) compounded fastest (Koninklijke Philips (PHG) -10.8%/yr, Lantheus Holdings (LNTH) +34.7%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Koninklijke Philips (PHG) has been the steadiest (Koninklijke Philips (PHG) 28.8%, Lantheus Holdings (LNTH) 32.4%, Heartflow (HTFL) 76.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, PHG, LNTH and HTFL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Lantheus Holdings (LNTH) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.